Similarly, mesenchymal stem cell-derived miR-150-5p targeting membrane-type matrix metalloproteinase 14(MMP14), and VEGF reduced angiogenic activity and clinical arthritis scores in arthritic mice (Chen et al., 2018). This evidence concerns the gene VEGFA and arthritic joint disease.